Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Regulatory and safety status: Pending FDA review
Malinda, K
Common Side Effects: Clinical trials involving approximately 900 participants indicate that AOD-9604 is generally well-tolerated with a favorable safety profile
Experimental models have shown accelerated collagen fiber organization, fibroblast activation, and improved tensile strength following injury
reconstituted vials must be maintained under constant refrigeration at 2C to 8C
Comparison CompoundClassPathway / targetResearch focusFormat 5-Amino-1MQSmall moleculeNNMT inhibitionNAD / SAM metabolismVial 5-Amino-1MQ CapsulesSmall moleculeNNMT inhibitionNAD / SAM metabolismCapsules SLU-PP-332Small moleculePan-ERR agonismMitochondrial gene expressionVial SLU-PP-332 CapsulesSmall moleculePan-ERR agonismMitochondrial gene expressionCapsules Tesofensine CapsulesSmall moleculeMonoamine reuptakeCNS / monoaminergic signallingCapsules Enclomiphene CapsulesSmall moleculeEstrogen receptor (SERM)HPG-axis signallingCapsules AICARSmall moleculeAMPK activationCellular energy sensingVial AOD-9604Peptide fragmenthGH fragment (176-191) signallingLipolytic-pathway signallingVial AOD-9604 CapsulesPeptide fragmenthGH fragment (176-191) signallingLipolytic-pathway signallingCapsules GLP-3 (Reta)PeptideIncretin receptorMetabolic signalling researchVial Every compound in this category is supplied as Research Use Only material with: Peer-reviewed literature and mechanism background underpinning this category are maintained in the linked research articles below
US$ 25.73
US$ 21.27
US$ 25.85
US$ 26.83
US$ 25.18
US$ 27.60